Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000814443 | SCV000954853 | benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2024-10-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001566822 | SCV001790400 | uncertain significance | not provided | 2024-06-03 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Revvity Omics, |
RCV001566822 | SCV003833307 | uncertain significance | not provided | 2023-02-16 | criteria provided, single submitter | clinical testing | |
Genome |
RCV000814443 | SCV004228664 | not provided | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 05-10-2019 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. |